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Abstract
Expression levels of human genes vary extensively among individuals. This variation facilitates analyses of expression levels
as quantitative phenotypes in genetic studies where the entire genome can be scanned for regulators without prior
knowledge of the regulatory mechanisms, thus enabling the identification of unknown regulatory relationships. Here, we
carried out such genetic analyses with a large sample size and identified cis- and trans-acting polymorphic regulators for
about 1,000 human genes. We validated the cis-acting regulators by demonstrating differential allelic expression with
sequencing of transcriptomes (RNA-Seq) and the trans-regulators by gene knockdown, metabolic assays, and chromosome
conformation capture analysis. The majority of the regulators act in trans to the target (regulated) genes. Most of these
trans-regulators were not known to play a role in gene expression regulation. The identification of these regulators enabled
the characterization of polymorphic regulation of human gene expression at a resolution that was unattainable in the past.
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Introduction
Expression levels of genes, like many phenotypes, vary among
normal individuals. Since gene expression underlies cellular char-
acteristics and functions, variation in gene expression contributes
to phenotypic diversity and differences in disease susceptibility.
Previously, we and others demonstrated that there is a genetic
basis to individual variation in gene expression [1–6]. This facili-
tates studies to identify sequence variants that influence expression
levels of genes. Since expression phenotypes of many genes are
studied in parallel, results from genetics of gene expression
(GOGE) studies contribute to the understanding of global gene
regulation.
GOGE studies that treated expression levels as quantitative
traits in family-based linkage [3,7] and population-based associ-
ation analyses [5,8,9] have uncovered polymorphic regulatory
regions that contribute to variation in human gene expression.
However, the regulatory regions were large, often megabases in
size; thus, the identity of most polymorphic regulators remained
unknown. In this GOGE study, we analyzed a large sample in
linkage analyses, then we used deep sequencing of transcriptomes
(RNA-Seq) to guide association-based fine mapping. The results
allowed us to narrow the regulatory regions and identify cis- and
trans-acting polymorphic regulators of ,1,000 human genes.
These results facilitated molecular validation and analyses of the
mapping data. This is an important advance in human genetic
studies where such validations have largely been impossible. In
previous human GOGE studies, the resolution of the mapping
results was inadequate; hence, regulators were not identified, while
other gene mapping studies focused on complex phenotypes, such
as human diseases that are often not amenable to molecular
analyses. Thus, the end points of many human genetic studies
showed genotype-phenotype connections statistically but not
molecularly.
Here, we have an unusual opportunity to begin to bridge the
gap between genetic and mechanistic studies. Knowing the
identity of the regulators, we were able to validate the cis- and
the trans-regulatory relationships using different approaches. For
genes that are cis-regulated, we used RNA-Seq to show differential
allelic expression. For the trans-regulatory relationships, we altered
the expression of the regulators by gene knockdowns and
metabolic perturbations and showed that manipulations of the
regulators affected the expression levels of the corresponding
target genes. We also demonstrated direct interactions between
PLoS Biology | www.plosbiology.org 1 September 2010 | Volume 8 | Issue 9 | e1000480regulators and their target genes by chromosome conformation
capture.
Another goal of this study is to examine the role of cis- and trans-
acting polymorphisms on human gene expression. Previously,
GOGE studies in model organisms and humans appear to
disagree on the proportion of polymorphic cis- and trans-acting
regulators. In yeast, fly, and mouse studies, most of the regulators
act in trans [2,10–12]. In contrast, human studies focused mostly
on cis-acting variants. This apparent discrepancy is likely due to
differences in sample sizes. Studies in model organisms used larger
sample sizes and thus were able to find trans-acting regulators that
have smaller effects on gene expression than cis-regulators [13,14].
In contrast, early human studies of GOGE used relatively small
sample sizes, such as samples collected by the International
HapMap Consortium [5,8]; hence they identified mostly cis-
regulators. This and the discovery of cis-regulation of disease
susceptibility genes such as ORMDL3 (asthma) [15] led to
suggestions that cis-acting variants are significant contributors to
variation in human gene expression. However, it is unlikely that
the regulatory landscapes are different between humans and other
organisms. In humans, trans-acting regulators possibly also play an
important role. Several studies [3,4,9] have suggestive evidence for
the important contribution of trans-acting variants. Recently,
studies that used RNA-Seq to analyze gene expression phenotypes
in HapMap samples found cis-acting variants for less than 10% of
human genes [16,17]. These studies suggest that along with cis-
variants, trans-acting polymorphisms contribute to individual
variation in human gene expression. Here, to address this, we
used a large sample size and identified hundreds of polymorphic
trans-regulators. These findings confirm that as in other organisms,
there are many sequence variants in the human genome that act in
trans to influence gene expression.
Many of the identified trans-regulators were previously not
known to play a role in gene regulation. Over 60% of the
regulators are not transcription factors or known signaling factors.
However, the trans-regulators are not randomly distributed;
instead they tend to be found in the same functional pathways
as their target genes. While the regulators were discovered in
analysis of immortalized B-cells, we showed that the regulatory
relationships were also found in primary fibroblasts. Thus, natu-
ral variation in gene expression allowed the identification of
polymorphic expression regulators, which then enabled us to
develop a deeper understanding of gene regulation.
Results
Linkage Scans
We obtained genotypes of single nucleotide polymorphisms
(SNPs) and measured the expression levels of genes in immortal-
ized B-cells from members of 45 Centre d’Etude du Polymor-
phisme Humain (CEPH) Utah pedigrees [18] using microarrays.
We focused our analysis on 4,793 expressed genes that show
variation in expression levels among individuals and carried out
genome-wide linkage analysis (see Methods). From those analyses,
we selected 1,681 (35%) phenotypes for further studies using a
threshold of t.4 (a logarithm of odds (lod) score of ,3.4, and a
genome-wide corrected significance level of approximately 0.05
[19]) (see Methods). Figure 1 shows examples of genome scan
results.
We expected to find polymorphic regulators of the expression
phenotypes in the candidate regions identified by the linkage
scans. Hence we examined the linkage peaks to determine their
locations relative to the genomic addresses of the target genes. To
take into account the imprecision of linkage, we define regulatory
regions that are within 5 Mb of the target genes as proximal and
those that are greater than 5 Mb or on another chromosome as
distal to the target genes [20]. By this definition, among the 1,681
phenotypes with evidence of linkage at t.4, we found that 70
(4.2%) phenotypes have proximal regulators, 1,574 (93.6%)
phenotypes have distal regulators, and 37 (2.2%) phenotypes have
both proximal and distal regulators. Ninety-four percent of the
distal regulators are on a different chromosome than their
corresponding target genes. These results suggest that trans-acting
regulation contributes appreciably to variation in gene expression.
Family-Based and Population Association
Linkage scans provided regulatory regions for over 1,600
expression phenotypes. To confirm these results, we carried out
family-based and population-based association analyses with
markers within the candidate regulatory regions. In addition to
confirming the linkage findings, association mapping allows us to
take advantage of historical recombinations in order to narrow the
candidate regions.
Proximal linkage peaks. For the 107 (70+37) phenotypes
where the linkage peaks are proximal to the target genes, we
assumed that they are likely to be cis-regulated, so we tested SNPs
within and 50 kb up- and downstream of the target genes. Among
these 107 phenotypes, we had informative genotypes for 100
phenotypes to carry out family-based association analysis by
quantitative transmission disequilibrium test (QTDT) [21]. From
the analysis of the members of the 45 CEPH pedigrees by QTDT,
63 of the 100 phenotypes showed significant evidence (nominal
p#0.001) for the combined presence of linkage and association
(Table S1). These results confirm the linkage findings and support
that these phenotypes are cis-regulated.
Using expression data and genotypes of 86 unrelated individ-
uals, we carried out population-based association analysis and
found significant evidence (nominal p,0.005) for population
associations between gene expression levels and SNPs within or
near the target genes (Table S1) for 47 (75%) of these 63
phenotypes. We also estimated the variation in expression
explained by the cis-acting determinants by calculating R
2 using
results of the linear regression analyses in population association
studies. For the 47 phenotypes, the average R
2 is 0.25
(range=0.09 to 0.75). For 17 of these phenotypes, the cis-variants
Author Summary
Cellular characteristics and functions are determined
largely by gene expression and expression levels differ
among individuals, however it is not clear how these levels
are regulated. While many cis-acting DNA sequence
variants in promoters and enhancers that influence gene
expression have been identified, only a few polymorphic
trans-regulators of human genes are known. Here, we used
human B-cells from individuals belonging to large families
and identified polymorphic trans-regulators for about
1,000 human genes. We validated these results by gene
knockdown, metabolic perturbation studies and chromo-
some conformation capture assays. Although these
regulatory relationships were identified in cultured B-cells,
we show that some of the relationships were also found in
primary fibroblasts. The large number of regulators
allowed us to better understand gene expression regula-
tion, to uncover new gene functions, and to identify their
roles in disease processes. This study shows that genetic
variation is a powerful tool not only for gene mapping but
also to study gene interaction and regulation.
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expression levels. This provides an estimate of the contribution of
cis-variants; the fraction not explained this way includes non-
genetic factors (including environment) and other genetic factors
not in linkage disequilibrium with the cis-acting determinants.
These findings further support the linkage results and provide
evidence of differential allelic expression of these genes (see
Figure 2 for examples). We also looked for molecular evidence of
cis-regulation (see section below on differential allelic expression
under ‘‘molecular validation’’).
Distal linkage peaks. We followed up results for the 1,611
(1,574+37) phenotypes with significant distal linkage peaks using
QTDT. Unlike proximal peaks where we can look for cis-acting
variants within or near the target genes, there are no obvious
regions to look in the distal peaks. This is particularly difficult
when the linkage peaks are large and contain several potential
regulators. One option is to test all the SNPs under the linkage
peaks for evidence of association with expression levels of the
corresponding target genes; however, that would result in a severe
multiple testing problem. Instead we identified the genes that are
expressed in our B-cells by RNA-sequencing and testing the
expressed genes for association with expression levels of their
corresponding target genes.
In RNA-sequencing, we are not limited to studying only genes
that are represented on the microarrays. With sufficient coverage,
sequencing data also allow us to detect genes that are expressed at
lower levels. This is important since gene expression regulators,
such as transcription factors, are often expressed at low levels. We
Figure 1. Genome scans of six expression phenotypes. The name of the target gene and its chromosomal location (in parenthesis) are shown.
Evidence of linkage as indicated by p value (2log10) is shown on the vertical axis and genomic locations are shown on the horizontal axis of each
graph. The top two panels are examples of phenotypes with proximal linkage peaks, and the bottom four panels are phenotypes with distal linkage
peaks.
doi:10.1371/journal.pbio.1000480.g001
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[22,23] individuals using the Illumina technology [24]. For each
sample, we obtained ,40 million reads, each 50 nucleotides long
or about 2 Gb of sequences per sample. We mapped the short
read sequences to the reference human genome (hg18) using the
software MAQ [25]. About 83% of the sequences mapped
uniquely to the reference sequence. The other 17% mapped to
multiple sites in the genome (repetitive sequences or sequence
motifs that are common in gene families) or failed to map
anywhere in the reference genome (including exon junctions
which would not map to the reference genome sequence). We
compared the expression levels of genes in B-cells of the same
individuals from RNA-Seq with those from our microarrays, the
average correlation was 0.76 (range=0.73 to 0.80, highly similar
to those in other studies [16,17,26]). We also compared genotypes
from our RNA-Seq to those from the HapMap Consortium and
found the average concordance rate was 98.6%. These results gave
us confidence in the data so we used them to identify expressed
genes in the candidate regions identified by linkage scans.
We tested SNPs in the expressed genes within each linkage
peak for association with their candidate target genes. For genes
that are expressed with RPKM$1 [26] in the linkage regions, we
carried out QTDT analyses using SNPs within and 5 kb up- and
downstream of the regulators in all members of the 45 CEPH
families. Among the 1,611 phenotypes with distal linkage peaks,
we excluded 94 phenotypes whose candidate regulatory regions
were over 20 megabases in size. Of the 1,517 remaining
phenotypes, the expression levels of 103 (6.8%) phenotypes
Figure 2. Allelic expression from RNA-Seq confirms prediction by association analysis. Graphical presentations of two genes that show
differential allelic expression. The thick lines represent the higher expressing allelic forms of CHI3L2 and CRYZ (A). Regression of expression
phenotypes (expression levels shown on vertical axis) of two genes on nearby SNPs (genotypes shown on horizontal axis) (B). Number of reads
(vertical axis) from RNA-Seq for each allelic form (horizontal axis) of the genes; only data for individuals who are heterozygous at the coding SNPs are
shown. For each individual, the number of reads for each allele of an SNP is connected by a line. For example, in the panel for rs8535 (CHI3L2), the
individual represented by a red line had 268 reads of the A-bearing form of CHI3L2 and 49 reads of the C-bearing form of CHI3L2 (C).
doi:10.1371/journal.pbio.1000480.g002
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FDR=0.02) with SNPs in trans-regulators. Since trans-acting
regulators have weaker effect than cis-regulators, we also looked
at results using lower thresholds of p,0.01 and 0.05 (FDR 3 and
8%); there are 518 (34%) and 917 (60%) phenotypes that met
these thresholds, respectively. Among these 917 phenotypes, the
expression levels of 112 genes are influenced by two or more
unlinked polymorphic trans-regulators. Thus, the analysis re-
vealed 1,036 regulator–target gene pairs. Table 1 shows the top
20 trans-regulator–target gene pairs from our linkage and
association study (see Table S2 for the top 200 regulator–target
gene pairs). As we did for the cis-acting regulators, we tested the
trans-regulators identified by QTDT for allelic association with
their target genes using population association tests. Although the
sample size is small (n=86), we found significant association for a
set of trans-regulators and their target genes. Among the
regulators of the 917 target genes, SNPs in 58 (6%) and 318
(35%) regulators showed significant allelic association with
expression levels of their target genes at nominal p,0.005 and
p,0.05, respectively. To estimate the influence of these trans-
acting variants on individual variation in gene expression, we
calculated R
2 for the 318 phenotypes. The average R
2 is 0.07
(median=0.07; range=0.05 to 0.24). For 53 phenotypes, the
trans-acting variants explained 10% or more of the individual
variation in their expression levels. These results show that
individual differences in gene expression can be explained by
DNA sequence polymorphisms in trans-acting regulators.
Known and Newly Discovered Regulatory Relationships
To check the validity of these findings, we looked for known
regulatory relationships among the regulator–target gene pairs
that we identified in the genetic analyses. An example of such
known relationship is MRLC2, which encodes myosin regulatory
light chain 2 and its regulator myocyte enhancing factor 2A,
MEF2A, a transcription factor that is known to affect muscle gene
expression, including MRLC2 [27]. Our linkage results identified
chromosome 15q26 (linkage t=4.9) as the candidate regulatory
region for the expression level of MRLC2. Using association
analyses, we narrowed the candidate region and rediscovered
MEF2A as the regulator of expression level of MRLC2 (QTDT
p=0.008; population association p=0.04, rs325380). Another
example is TTC5 as the polymorphic regulator of HSP90AA1
expression. Previous studies showed that a mouse protein
phosphatase that contains a tetratricopeptide repeat regulates
heat shock protein 90; this regulation occurs by dephosphoryla-
tion, which is mediated by the binding of heat shock protein 90 to
the tetratricorepeat domain of the phosphatase [28,29]. Our
results showed that the expression of human HSP90AA1 is
influenced by variants in TTC5, a gene with a tetratricopeptide
repeat (linkage t=5.4; QTDT p=0.01, rs11623837). The
‘‘rediscovery’’ of these known regulatory relationships confirms
that our approach can identify trans-acting regulators of human
gene expression.
For the 20 regulator–target gene pairs in Table 1, we checked
for co-occurrence of the names of the regulators and target genes
Table 1. Expression phenotypes with the strongest evidence of linkage and association to polymorphic trans-regulators.
Target
Gene
Target
Gene
(Chr)
t
Value
1
Trans-
Regulator
Regulator
(Chr)
SNP
(QTDT)
2
p Value
(QTDT)
SNP
(Association)
p Value
(Association)
3
Expression Level
(Log2) by Genotype
PECAM1 17 5.54 PSMD8 19 rs2074981 2610
25 rs2074981 0.02 (4.62, 7.22, 6.85), (‘‘AA,’’ ‘‘AC,’’ ‘‘CC’’)
DLG5 10 5.21 TNIK 3 rs9814699 2610
25 rs9810370 0.03 (5.47, 5.93, 6.15), (‘‘AA,’’ ‘‘TA,’’ ‘‘TT’’)
TYMS 18 4.96 OPTN 10 rs17512962 2610
25 rs2095387 N.S. (13.02, 12.9, 13.04), (‘‘GG,’’ ‘‘TG,’’ ‘‘TT’’)
SSR1 6 4.58 ITPR2 12 rs12823128 2610
25 rs12823128 0.002 (11.01, 10.97, 10.69), (‘‘CC,’’ ‘‘TC,’’ ‘‘TT’’)
FOXG1 14 4.44 NAPB 20 rs2424534 2610
25 rs2252824 0.04 (3.83, 3.12, 4.41), (‘‘AA,’’ ‘‘AG,’’ ‘‘GG’’)
PARVA 11 4.23 VGLL4 3 rs6807423 2610
25 rs12374138 0.005 (6.02, 5.78, 5.23), (‘‘AA,’’ ‘‘AG,’’ ‘‘GG’’)
ATXN2L 16 4.21 ENOPH1 4 rs1980187 2610
25 rs6826022 N.S. (7.34, 7.32, 7.1), (‘‘CC,’’ ‘‘CT,’’ ‘‘TT’’)
PDE4B 1 5.89 MBP 18 rs9959822 3610
25 rs11150996 0.02 (8.36, 8.06, 7.92), (‘‘CC,’’ ‘‘CT,’’ ‘‘TT’’)
USP1 1 4.05 UXS1 2 rs17279736 3610
25 rs2167531 N.S. (10.65, 10.7, 10.83), (‘‘CC,’’ ‘‘CT,’’ ‘‘TT’’)
KHDRBS3 8 4.72 FAM120B 6 rs910424 4610
25 rs1022615 0.002 (4, 4.92, 6.22), (‘‘CC,’’ ‘‘GC,’’ ‘‘GG’’)
ZNF189 9 4.85 ARHGAP10 4 rs6822971 8610
25 rs7660368 N.S. (8, 8.03, 8.27), (‘‘CC,’’ ‘‘TC,’’ ‘‘TT’’)
USPL1 13 4.68 COG1 17 rs1026129 9610
25 rs1026128, N.S. (8.32, 8.33, 8.34), (‘‘AA,’’ ‘‘AG,’’ ‘‘GG’’),
IFNA2 9 4.81 C3orf1 3 rs1967621 1610
24 rs1967621 N.S. (4.29, 4.61, 4.68), (‘‘CC,’’ ‘‘GC,’’ ‘‘GG’’)
PDCD10 3 4.72 ZNF429 19 rs2650825 1610
24 rs2650825 N.S. (10.66, 10.75, 10.83), (‘‘CC,’’ ‘‘CT,’’ ‘‘TT’’)
MLYCD 16 4.64 DNAJC25-
GNG10
9 rs1322251 1610
24 rs10817199 N.S. (7.66, 7.65, 7.27), (‘‘CC,’’ ‘‘GC,’’ ‘‘GG’’)
KCNMB3 3 4.57 IPO8 12 rs3910561 1610
24 rs33270 0.04 (5.93, 5.43), (‘‘AA,’’ ‘‘GA’’)
STXBP3 1 4.38 DCUN1D2 13 rs3814254 1610
24 rs2261120 N.S. (7.5, 7.54, 8.07), (‘‘CC,’’ ‘‘TC,’’ ‘‘TT’’)
ATXN2 12 4.86 NFATC2 20 rs4811172 2610
24 rs6067803 0.03 (8.11, 8.18, 8.4), (‘‘GG,’’ ‘‘GT,’’ ‘‘TT’’)
LIN7A 12 4.49 YLPM1 14 rs2241275 2610
24 rs957345 N.S. (7.52, 6.89, 6.83), (‘‘CC,’’ ‘‘CG,’’ ‘‘GG’’)
ETV6 12 5.04 KCNQ5 6 rs16883476 2610
24 rs16882712 N.S. (7.92, 7.41, 7.76), (‘‘AA,’’ ‘‘AG,’’ ‘‘GG’’)
1From linkage scans (S.A.G.E./sibpal) of 45 families (.1,000 sibpairs).
2QTDT of all members of 45 families.
3Population association of 86 unrelated individuals.
N.S.=not significant (p.0.05). The sample size for population association is much smaller than ones for the linkage and QTDT analyses.
doi:10.1371/journal.pbio.1000480.t001
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determine if any of these regulatory relationships are known. We
also queried PubMed for such co-occurrences. Among these 20
pairs, only one pair (MBP and PDE4B) has been shown to have
interactive relationships in Chilibot. Thus, many of these
regulator-target relationships are likely unknown previously.
Molecular Validation
RNA-Seq to identify differential allelic expression in cis-
regulated genes. To validate the polymorphic cis-regulation
identified in our mapping study, we used the RNA-Seq data of
individuals in the HapMap Project as described above. We used
the sequencing data to assess differential allelic expression (DAE)
[16,17,22,23].
The digital nature of the sequence data allows us to use the
heterozygous genotypes in each transcript to determine whether
two allelic forms of a transcript are expressed in equal abundance
[31–33]. Among the 107 expression phenotypes with proximal
linkage peaks, 67 have at least one SNP where there are 2
individuals who are heterozygous at that SNP (see Methods). We
examined these heterozygous samples for evidence of DAE. For
many of these genes, we have data for multiple SNPs from an
average of 7.2 individuals (median=6). Among the 67 genes, 43
genes (64%) showed significant evidence (p,0.01, chi-square test)
of departure from equal expression of the two allelic forms of the
genes. For the 273 exonic SNPs in these 43 genes, we calculated
an ‘‘allelic expression ratio’’ a/(a+b), where a and b are the
numbers of sequence reads for the two alleles. Figure S1 shows
these allelic expression ratios and their departures from 0.5. For 31
of these genes, the exonic and the associated SNPs from our
mapping study are part of the markers in the HapMap Project
[23]; thus phased haplotype data are available. Using these
haplotypes, we showed that for 28 (90%) genes, the predicted
expression in the association study was confirmed by RNA-Seq
data (see Figure 2 for examples). Hence, the DAE results confirm
the findings from our mapping studies and show that the majority
of genes (,65%) with proximal linkages are cis-regulated. For the
remaining phenotypes, either we do not have adequate sample size
or read coverage to detect subtle evidence of DAE, or they are
regulated by trans-regulators that mapped close to the target genes.
Our sequence data allow us to examine DAE of many more
genes in addition to those with proximal linkage peaks. There are
5,782 genes that can be studied for DAE. Among them, 1,029
(18%) and 1,501 (26%) genes showed significant evidence of DAE
at p value (chi-square test) thresholds of 0.001 and 0.01,
respectively. The 18% to 26% of genes that show DAE provide
another estimate of the number of genes in our B-cells that are cis-
regulated. This proportion is similar to the 12% estimated by Price
and colleagues using admixture analysis [34], the 30% by Pastinen
and colleagues by hybridization of cDNA to SNP arrays [35], the
11% to 22% by Church and colleagues using RNA-Seq, and our
mapping study (we found 6.5% and 24% of phenotypes to have
proximal peaks, at t threshold of 4 and 5, respectively).
Molecular validation of trans-acting regulators: gene
knockdown. To validate the trans-regulator–target gene
relationships, we carried out molecular analyses. First, we
performed gene knockdown studies. We used short interfering
RNA (siRNA) to silence 25 potential regulators, and then assessed
the effects by measuring the expression of the target genes (we
tested cells from 4 to 6 individuals) [36]. Among the 25 regulators,
we included MEF2A and TTC5 as positive controls. The
remaining 23 regulators were selected based on availability of
siRNAs and they span a range of QTDT significance from
p=10
25 to 10
22 (for BLM-NUSAP1). We did not select regulators
that were supported by the most significant p-values. We reasoned
that if we can confirm molecularly the regulators with relatively
modest statistical supports, then the ones with more significant
mapping results are likely to be true regulators.
Among the 25 regulators, successful knockdown was achieved
for 18 regulators. The expression of these regulators including
MEF2A and TTC5 decreased significantly (p,0.05) by about 20%
to 85% in four or more independent samples, whereas no changes
in the expression of the regulators were observed when siRNAs
with no homology to the regulators were used (Table 2). We then
measured the expression levels of the target genes following
knockdown of their regulators. The expression levels of 13 (72%)
target genes including MRLC2 (target of MEF2A) and HSP90AA1
(target of TTC5) changed significantly (p,0.05) following the
knockdown of their regulators (Table 2). The expression levels of
the target genes, such as NUSAP1 (encodes a spindle associated
protein) and SSR1 (signal sequence receptor alpha), changed by
,10% to 60%, while those of non-target control (GAPDH) did not
change significantly after the knockdown of the regulators,
suggesting that the changes in expression levels of the target genes
were specific effects of silencing their regulators.
We followed up three of these regulator–target gene pairs in
primary fibroblasts (n=2) to determine the cell-type specificity of
the regulatory relationships. We carried out siRNA-mediated
knockdown of BLM, ITGB4BP, and PSAP in fibroblasts. Following
the silencing of BLM and ITGB4BP, we observed significant
changes (p,0.05, t test) in expression of their target genes NUSAP1
and SLC25A11 as in the immortalized B-cells (Table S3A).
However, the expression of HMGCS1 did not change significantly
following knockdown of its regulator, PSAP, suggesting that this
regulatory relationship may be specific for B-cells.
These results provide molecular support for the regulator–target
gene relationships identified in our mapping studies. However, the
lack of changes in expression levels of the target genes following
the knockdown of their regulators does not argue against the
regulatory relationships. The expressions of the regulators were
only partly decreased by siRNAs; partial expression may be
sufficient for regulation. In addition, many human genes have
other family members that take over their functions upon
knockdown of their expression.
INSR and its target genes. In addition to knockdown
studies, we carried out another functional analysis that does not
rely on transfection. One of the trans-regulators is the insulin
receptor, INSR. Our mapping results identified six genes, ADD3,
ARNT, ATIC, CCL5, LTB, and PSMD10, whose expression levels
are regulated by the insulin receptor, INSR. Previously, studies
have shown that ADD3 is involved in insulin receptor signaling
[37]. In addition, Kahn and colleagues showed that following
knockdown of ARNT, the expression of the insulin receptor was
decreased in pancreatic islet cells [38]. If our mapping results are
correct, then it would suggest that insulin receptor regulates the
expression of ARNT, providing evidence of reciprocal regulation of
ARNT and INSR or feedback mechanisms. To validate these
regulatory relationships, we stimulated the insulin receptor by
treating primary fibroblasts with insulin and measured the
expression levels of INSR and its target genes. The fibroblasts
allowed us to confirm the regulatory relationship in primary cells.
Among the six genes, four (ADD3, ARNT, ATIC,a n dPSMD10)w e r e
expressed in fibroblasts, so we focused our analysis on these genes.
We treated the cells with insulin; upon insulin treatment, the insulin
receptor is activated but not the related IGF1 receptor, thus
indicating that insulin was acting specifically through INSR
(Figure 3). Insulin led to a biphasic response of INSR:2ha f t e r
insulin treatment, the expression level of INSR among four
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25); this was
followed by a 48% decrease (p=0.004) at 6 h after exposure to
insulin (Table 3). The expression levels of the four target genes also
changedsignificantly(p,0.005)followinginsulintreatment(Table3).
These findings confirm our mapping results, which identified INSR
as the polymorphic regulator of expression of ADD3, ARNT, ATIC,
and PSMD10. They show that the regulatory relationships identified
in immortalized B-cells are also found in primary fibroblasts.
Physical interactions between regulators and their target
genes. We used data from chromosome conformation capture
(3C) as additional validation of the regulatory relationships and to
identify regulatory pairs that interact physically. Recently, using
the same immortalized B-cells, Dekker and colleagues combined
3C with high-throughput sequencing, in a procedure they coined
‘‘Hi-C,’’ to identify regions of the human genome that interact
physically [39]. We used their data to determine if any of our
1,036 regulator–target gene pairs (with population association
p,0.05) interact. We found 75 of our gene pairs in their data
(corresponding to 63 unique regulator–target gene pairs; some
pairs were found more than once; see Table 4 and Table S7). The
chance of finding two genes as regulatory pairs in our mapping
study and as interacting partners in the Hi-C experiment by a
different group randomly is very small; thus we believe that these
are likely true interactions. The Hi-C results further confirm
findings from our genetic studies. These data suggest that the
regulators and their target genes may be co-transcribed in
‘‘transcription factories’’ [40–42].
Since the Hi-C libraries were not sequenced exhaustively [39],
some of our pairs may not be included in their results even though
they interact physically. Nevertheless, the results provide addi-
tional information for some of the regulatory relationships and
show that similar approaches can be used to extend the analysis.
Characteristics of the Trans-Regulators
The resolution of our mapping study allowed us to identify the
polymorphic regulators of nearly 1,000 human genes. Instead of
just confirming these results computationally, we used molecular
approaches, which provide an independent method for assessing
Figure 3. INSR activation following insulin treatment in human primary fibroblasts. Fibroblasts were serum starved for 18 h and then
treated with 100 nM insulin for 5 min. Cell lysates were incubated with a-INSR or a-IGF1R antibodies. Input and immunoprecipitated products were
analyzed by western blots using a-phosphotyrosine, a-INSR, or a-IGF1R antibodies.
doi:10.1371/journal.pbio.1000480.g003
Table 2. Results of knockdown of trans-regulators.
Changes in Expression Levels of
Regulator–Target Gene* Regulator{ Target Gene{ Control (GAPDH){
AIG1-TMEM50A 251.067.8 17.162.9 20.4613.2
BLM-NUSAP1 239.267.7 23.363.7 0.163.3
CLTA-GCA 284.266.3 22.265.3 14.561.5
FAM120B-KHDRBS3 271.461.2 26.561.2 5.867.2
GALNTL4-PTPRG 277.564.1 36.7611.8 23.7611.1
GPHN-RALB 272.664.6 40.768.7 14.7612.0
HSP90AB1-STK24 279.064.7 14.465.3 9.264.7
ITGB4BP-SLC25A11 264.464.3 65.767.8 0.260.4
ITPR2-SSR1 221.468.5 20.166.1 7.1611.6
MEF2A-MRLC2 233.969.3 228.162.6 12.768.5
PSAP-HMGCS1 268.565.1 11.966.2 2.764
TTC5-HSP90AA1 287.363.1 243.8612.8 22.6614.9
VGLL4-PARVA 265.967.3 56.5614.2 15.267.9
*All experiments were based on independent siRNA knockdown of four or more samples.
{Expression levels of the regulators and target genes changed significantly (p,0.05, t test) compared to baseline (without siRNA knockdown). Results are shown as
mean 6 S.E.M.
{Expression level of a control, GAPDH, did not change significantly (p.0.05) upon siRNA knockdown of the regulators. Results are shown as mean 6 S.E.M.
doi:10.1371/journal.pbio.1000480.t002
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had modest statistical support (p=10
25 to 10
22) from our
mapping study, over 70% of the regulatory pairs are validated
molecularly. Thus, we are reasonably confident that many of the
1,036 gene pairs have true regulatory relationships, so we went on
to characterize them.
First, many of the trans-regulators were not known to influence
gene expression. Among the 742 regulators, 112 (15%) are known
transcription factors and 140 (19%) play a role in signaling
pathways. The remaining genes have a variety of functions
including metabolism (for example, MAN2A1, PDHA2) and protein
transport or modification in the endoplasmic reticulum (for
example, LMAN1, SEC31A).
Second, the target genes and their regulators often belong to the
same functional pathways. For example, midasin (MDN1), which
plays a role in protein processing [43], regulates the expression of
dynactin 1 (DCTN1) and signal sequence receptor, delta (SSR4).
Both of these target genes also participate in protein transport and
processing in the endoplasmic reticulum [44,45]. To test formally
whether regulators and their target genes belong to the same
functional groups more often than by chance, we annotated the
regulators and target genes using Gene Ontology [46]. We found
significantly (p=0.008) more regulator–target gene pairs with the
identical ontology annotation than random pairs of genes. The
criterion we used is quite stringent since we required members of a
gene pair to have the identical ontology grouping; it excludes
regulator–target gene pairs that are in the same pathway but do
not have the identical ontology. However, despite the stringent
criterion, a significant result was obtained. Recent results from
yeast studies also showed that regulators and their target genes
share common gene ontology annotations [47].
Third, many of the trans-regulators have more than one target
gene. We found 161 (22%) of the 742 trans-regulators influence the
expression levels of two or more genes. Table 5 shows the 11
regulators that influence six or more target genes. Three of these
regulators are known to play a role in transcription regulation
through chromatin modification (AEBP2) or as transcription
factors (BCL2, ZCCHC2). In addition, three of the regulators
(PHLPP, RAMP1, WDR7) affect gene expression through signal
transduction pathways. The remaining five regulators are not
known to be gene expression regulators, including TTC5, which
has no known function.
Gene Network
The regulators with multiple target genes prompted us to
examine interactions beyond the relationship between a gene and
its regulator. To do so, we used our mapping results to construct
Table 4. Examples of regulator–target gene pairs that interact physically based on Hi-C experiments* [39].
Regulator Target t Value SNP (QTDT) p Value (QTDT) Hi-C Coordinate (Regulator) Hi-C Coordinate (Target)
ATRN NFIB 5.7 rs151507 0.01 chr20:3566294 chr9:14180554
USO1 WDR13 5.64 rs324734 0.004 chr4:76912713 chrX:48351440
CTNNBIP1 DDX58 5.63 rs935073 0.0009 chr1:9873467 chr9:32472537
ROBO1 ATF6 5.38 rs1507417 0.02 chr3:79217935 chr1:160093368
TMEM45A KCNMA1 5.06 rs6799992 0.01 chr10:101764442 chr10:78646999
KCNQ5 ETV6 5.04 rs16883476 0.0002 chr6:73892628 chr12:11800513
KCNQ5 ETV6 5.04 rs16883476 0.0002 chr6:73522933 chr12:11841656
KCNMA1 HMGCS1 5.04 rs11002137 0.006 chr10:78782737 chr5:43334692
KCNMA1 HMGCS1 5.04 rs11002137 0.006 chr10:78778388 chr5:43334974
PRKCE LIG4 4.99 rs2711295 0.0004 chr2:45893756 chr13:107664041
PHLPP PFKL 4.88 rs2053600 0.03 chr18:58718878 chr21:44555603
ROBO1 VRK2 4.83 rs9838937 0.001 chr3:79422794 chr2:58139091
ROBO1 VRK2 4.83 rs9838937 0.001 chr3:79020607 chr2:58189813
SDCCAG8 ACBD3 4.82 rs11800122 0.008 chr1:241614818 chr1:224416160
SDCCAG8 ACBD3 4.82 rs11800122 0.008 chr1:241640785 chr1:224442930
SDCCAG8 ACBD3 4.82 rs11800122 0.008 chr1:241732306 chr1:224420181
DIS3L2 GLTSCR2 4.82 rs3100608 0.01 chr2:232554756 chr19:52951146
WWOX IMPA2 4.82 rs11150104 0.002 chr16:76861753 chr18:11973686
SDCCAG8 NDEL1 4.81 rs10803140 0.009 chr1:241615074 chr17:8316669
SMYD3 COX4NB 4.75 rs2105158 0.003 chr1:244566879 chr16:84369002
*This table shows only the regulator-target pairs with the most significant linkage evidence. The complete list is given in Table S7.
doi:10.1371/journal.pbio.1000480.t004
Table 3. Changes in expression levels of insulin receptor
target genes following insulin treatment.
Time Point Following Insulin Treatment
Gene Names 1 h 2 h 6 h 12 h
INSR 11% 12%* 248%* 2%
ARNT 23%* 29%* 239%* 216%*
ATIC 22%* 3%* 49%* 82%*
ADD3 7%* 10%* 219%* 237%*
PSMD10 13% 12%* 28% 13%*
*p,0.005 compared to no treatment (t test, n=4).
doi:10.1371/journal.pbio.1000480.t003
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genes using results from the QTDT analysis. The resulting
network consists of 1,036 connections among 742 regulators and
917 target genes. As in many biological networks, the network
connections follow a scale-free distribution (scale-free criteri-
on=0.98) [48]. On average, genes have 1.3 connections, but some
genes have more connections such as those that regulate the
expressions of several target genes. Figure 4 shows subnetworks for
KIAA1468 and WDR7, which illustrate that some regulators have
multiple target genes and some genes are regulated by more than
one regulator. Unlike many gene networks, the nodes in our
networks are connected by directed edges based on genetic data.
DNA variants in the highly connected genes such as KIAA1468
and WDR7 influence the expression of many genes that are
directly and indirectly connected to them. The WDR7 subnetwork
shows the connections between ITPR2 and SSR1, as well as several
other genes, including SYNCRIP [49] and RHOC [50], that play a
role in the endoplasmic reticulum; thus polymorphisms in WDR7
likely affect protein processing and secretion, the primary functions
of the endoplasmic reticulum. Prior to this analysis, the function of
WDR7 was unknown except that it has been found to influence the
age of onset of multiple sclerosis [51] in genome-wide association
studies. Results from our analyses offer WDR7 as a mechanistic
link between multiple sclerosis and functions of the endoplasmic
reticulum. The efficiencies of the endoplasmic reticulum can
influence susceptibility to multiple sclerosis in different ways. First,
studies have shown that the endoplasmic reticulum plays a key role
in immunity, for example in ensuring the maturation of B-cells
to immunoglobulin secreting plasma cells [52]. In addition,
during myelination, cells such as oligodendrocytes rely on the
endoplasmic reticulum to produce a large amount of plasma
membrane [53]. Thus by altering the efficiencies of endoplasmic
Table 5. Trans-regulators with six or more target genes.
Regulator Target Genes
AEBP2 CAPNS1, CGRRF1, HIVEP1, LOC642732, MED4, PARVB
BCL2 AES, CPNE1, PDAP1, PMVK, TAGLN2, ZFPL1
KIAA1468 CD44, F11R, HNRPDL, MLLT10, PRKCSH, PSMD12, TDG, YTHDF2,
ZWINT
KMO ABCF2, EIF1, HEXB, TNFRSF14, ZMYM2, ZNF330
MDN1 AES, DCTN1, EMP3, MRPL23, PDHX, SSR4
PHLPP ANXA6, CSTF1, NRBP1, PFKL, RAB11B, SLC37A4, STK19, VAV2
RAMP1 GAPDH, LOC645899, PLK1, RPL23A, RPL32, RPL41, RPS13, RPS15,
RPS17, RPS18, RPS23, RPS24, RPS4X
TTC5 C11orf10, GLUD2, HSP90AA1, RPS3A, USP3, USPL1
USP40 ACTG1, RPL22, RPLP1, RPS10, RPS3A, RS3A
WDR7 APPBP1, ATP5G2, BCAS2, LOC642732, PIK3CB, RCC1, RHOC,
SPAG7, SYNCRIP
ZCCHC2 BTBD2, CD37, CNOT3, DDX10, EML2, GNAI2, GNB2, PPP2R1A
doi:10.1371/journal.pbio.1000480.t005
Figure 4. Directed subnetworks. Regulators are connected to their target genes based on results (p,0.05) from QTDT analyses. Directions of the
arrows go from regulators to their target genes. The two examples correspond to genes connected to KIAA1468, a gene with no known function (a),
and WDR7, a gene associated with age of onset of multiple sclerosis (b) [51].
doi:10.1371/journal.pbio.1000480.g004
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to multiple sclerosis through the autoimmune and/or myelination
pathways. Besides WDR7, other regulators in our network have
also been identified as disease susceptibility genes (see examples in
Figure S2).
Discussion
The main focus of this study is to assess and determine the
polymorphic regulation of human gene expression. We used
linkage analyses to locate the polymorphic regulatory regions for
1,681 human genes. About 6% to 24% of these regulatory regions
were close (proximal) to the target genes, and the remaining
regions were further away (distal) from the target genes and mostly
on other chromosomes. In follow-up association studies and
sequence-based DAE analyses, at least 60% of phenotypes with
proximal linkage peaks were found to be cis-regulated; this result is
similar to findings in yeast [2,11]. The remaining phenotypes with
proximal linkages are likely regulated by trans-regulators that are
close to their target genes. For 917 genes with distal linkage peaks,
we narrowed the regulatory regions and identified the trans-acting
polymorphic regulators. For some genes, we identified more than
one trans-regulator; thus, the results include a total of 1,036
regulator–target gene pairs. Previous genetics of human gene
expressions studies uncovered only the regulatory regions; here, we
improved the resolution significantly by finding the individual
regulators.
The results allowed us to explore previously unknown aspects of
gene regulation. We found that many genes besides transcription
factors can influence the expression of other genes. Similar results
were found in yeast [2,54]. Only 34% of the polymorphic trans-
regulators that we identified are transcription or signaling factors.
Many of the regulators are found in the same functional pathways
as their target genes. By eliminating the recruitment of regulators
from other pathways, cells can alter gene expression quickly when
a cellular process requires a gene to be turned on or off. We do not
know yet how polymorphisms in these genes influence expression
in trans. One possibility is that the sequence variants in or near the
regulators affect their own message and protein levels (cis-
regulation) and lead to differential expression levels of the target
genes that they regulate (trans-regulation). Based on our RNA-Seq
data, ,20% of the trans-regulators show such DAE or cis-
regulation. Alternately, the sequence variants in the regulators can
affect their structures, stabilities [55–57], and functions by
changing modifications such as phosphorylation status [58]; these
in turn can affect the expression of their target genes. We also do
not know whether the regulatory relationships are direct or
indirect. Since regulatory relationships are highly complex and
most genes are regulated by multiple genes in different feedback
mechanisms, we expect most regulatory relationships are indirect.
The Hi-C data show that some of the regulator–target gene pairs
interact physically at the DNA level; the results imply that they
may be co-transcribed perhaps in ‘‘transcription factories’’ [40,41]
where others have found trans interactions among regulators and
their target genes [42].
Although the regulatory mechanisms remain unknown, we
found that regulatory relationships are shared among cell types.
For a number of genes, the trans-regulatory relationships that we
identified in immortalized B-cells are also found in primary
fibroblasts. Others have found that cis-regulation of some genes is
shared across cell types [4,9,59,60]; here, we provide evidence that
trans-regulation can also be shared across different cells. This is
important since many cell types in humans are not easily
accessible. These results suggest that it may be possible to use
more readily available cells for analysis and apply the results across
cell types.
Our results have implications beyond regulation of gene
expression. It provides insight into disease mechanisms. We
already discussed the role of WDR7 as regulator of genes in the
endoplasmic reticulum and the implication of this finding for
multiple sclerosis. There are additional examples: for instance, we
identified inositol 1,4,5-triphosphate receptor, type 2 (ITPR2)a sa
regulator of signal sequence receptor, alpha (SSR1, also known as
TRAPA). Both genes function in the endoplasmic reticulum [45,61]
and are susceptibility genes for amyotrophic lateral sclerosis (ALS)
[62,63], but the connection between them was previously
unknown. By showing the regulatory relationship between these
two endoplasmic reticulum genes, we implicate inefficient
endoplasmic reticulum function in the development of ALS. The
role of the endoplasmic reticulum in ALS is further supported by
another regulator–target gene pair, ALS2 and its target gene,
SEC22A. ALS2 is the mutated gene in juvenile ALS [64]. Despite
several knockouts of Als2 in mice, its role in ALS has not been
identified. Here, we found that it regulates expression of SEC22A
(linkage t=5.6, QTDT p=0.004 rs3219171), which mediates
endoplasmic reticulum to Golgi transport. These findings have
therapeutic implications; a recent study suggested that survival of
ALS mice can be extended by blocking endoplasmic reticulum
stress induced cell death [65].
Unraveling the control of gene expression of human cells is
critical for understanding normal cellular processes and disease
mechanisms. It is difficult to identify trans-acting regulators. They
are not restricted to regulatory genes such as transcription factors.
The hundreds of regulators identified in our study do not share
protein domains nor belong to particular protein families. Thus,
the search cannot be guided by known regulatory functions or
protein domains alone. We show that GOGE study along with
RNA-Seq and molecular analyses allow the identification of cis-
and trans-acting regulators of human gene expression. This
approach makes it possible to determine how individual genes
are regulated and to discover regulatory pathways that maintain
cellular functions in human cells.
Materials and Methods
CEPH Samples, Genotypes, and Expression Phenotypes
The data were from members of 45 three-generations CEPH
families (CEPH 1328, 1330, 1331, 1332, 1333, 1334, 1340, 1341,
1344, 1345, 1346, 1347, 1349, 1350, 1353, 1354, 1356, 1357,
1358, 1362, 1375, 1400, 1408, 1413, 1416, 1418, 1420, 1421,
1423, 1424, 1444, 1447, 1451, 1454, 1456, 1458, 1459, 1463,
1477, 1582, 13281, 13291, 13292, 13293, 13294). Low-density
genotypes for 4,600 autosomal SNP markers were obtained using
the Illumina Linkage Panel (v3). We used PedStats [66] to check
for mendelian inconsistencies. This resulted in the removal of 297
genotypes at 209 distinct SNP markers. High-density genotypes for
some of the grandparents and parents were obtained from the
International HapMap Project (HapMap 22), and for those
families who are not part of the HapMap project, the parents
and one randomly selected child in each family were genotyped
using the Human SNP Array 5.0 (Affymetrix), which assays for
,500,000 SNP loci throughout the human genome. Then, high
density genotypes for family-based association (QTDT) on all
subjects were obtained by inference using the low-density geno-
types and high-density genotypes on selected individuals [67].
For expression analysis, immortalized B cells were grown at a
density of 5610
5 cells/mL in RPMI 1640 with 15% fetal bovine
serum, 2 mM L-glutamine, and 100 U/mL penicillin-streptomy-
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Human Focus Arrays (Affymetrix; ,8,500 RefSeq Genes on each
array). Samples were grown and processed in random order to
minimize batch effects. Samples of sibs were processed together
only by chance. Expression intensity was scaled to 500 using the
global scaling method implemented in the Expression Console
software from Affymetrix and transformed by log2.
The RNA samples for 94 CEPH grandparents (from the 45
families) were hybridized onto duplicate arrays. This allows us to
calculate ‘‘variance ratio’’ as a measurement of variability in
expression levels among individuals relative to the measurement
noise. For each expressed gene (called ‘‘present’’ by Affymetrix
Expression Console in 80% or more grandparents), we calculated
this measure as the ratio of the variance in mean expression levels
among individuals to the mean of the variance of the replicates
within individuals: (variance of Mi)/(mean of si
2). There are 4,793
genes with a variance ratio .1. We focused on these genes in our
analyses.
Analysis of Linkage and Association
Multipoint genome-wide linkage analysis was done by SIBPAL
in S.A.G.E. (http://darwin.cwru.edu/) [68]. We used the ‘‘W4’’
option [69] for weighting pairwise phenotypic differences between
siblings. SIBPAL determines evidence for linkage at each SNP
from regression of the phenotype difference between siblings on
the estimated proportion of marker alleles shared identical-by-
descent between siblings; the result is reported as a t value with
corresponding significance. Point-wise significance was converted
to genome-wide significance for multiple testing of markers by use
of the expression of Lander and Kruglyak (as implemented at
http://www.imbs-luebeck.de/8859-15/software/silclod.html)
[19]. In SIBPAL linkage analysis, for each family phenotypic data
of the children were used, and those for the grandparents and
parents were not used.
Family-based association analysis with SNPs near and within
the target genes or candidate regulators was carried out using
QTDT [21,70]. We tested about nine genes (median) per (trans)
linkage peak. Within a gene, the SNP markers are often in strong
linkage disequilibrium and thus are not independent tests. We
report nominal p values for the QTDT results. In the linkage
analysis, we used only data from children in the CEPH families;
however, in the QTDT analysis, we used data from all members of
the CEPH families. For the QTDT, we used the orthogonal (ao)
model [21] and variance component options (wega).
We carried out population association analysis to follow-up
results of QTDT. For these studies, expression phenotypes from
86 unrelated parents in the 45 CEPH families, as dependent
variables, were regressed on SNP genotypes (coded 0, 1, 2).
Conventional analysis of linear regression was carried out; we
tested SNPs within a gene that showed significant QTDT for each
phenotype. To minimize multiple testing, for each significant trans-
linkage peak, we tested only the gene where the most significant
QTDT result was found; SNPs within these genes are mostly
highly correlated so we did not consider them as independent tests.
We reported the nominal p values for these tests.
RNA-Seq
mRNA-Seq was performed as recommended by the manufac-
turer (Illumina). Briefly, immortalized B-cells from 41 unrelated
CEPH grandparents (part of the International HapMap Project
and the 45 families in this study) were grown and processed for
RNA-Seq; hence these are biological replicates of those used in
our microarray-based analysis. Poly(A) mRNA was extracted using
Dynal oligo(dT) beads, fragmented, and first strand cDNA
generated using random hexamers. Following second strand
cDNA synthesis, end repair, and addition of a single A base,
Illumina adaptors were ligated onto the samples. Then, ,200 bp
fractions of the cDNA samples were isolated from agarose gels and
PCR amplified. The qualities of the PCR amplicons were checked
using the Agilent Bioanalyzer. The samples were then sequenced
using the Illumina Genome Analyzer. We obtained an average of
41 million 50 bp reads per sample (median=40 million).
For alignment of the short reads sequences to the human
reference sequence (hg18) and identification of SNPs, we used the
program MAQ (version 0.6.8) [25]. To minimize sequence errors,
we used the first 40 of the 50 nucleotides in each sequence read for
our analysis. For the alignment, we used the default settings of
MAQ: allowing up to two mismatches per read. From the aligned
reads with map quality scores of 30 or higher, we identified SNPs.
For this analysis, we used only known SNPs in dbSNP Build 129.
For a sample to be heterozygous at a SNP for our DAE analysis,
we required that each allele be represented in at least 5% of the
total reads covering that locus. To determine the expression level
of a gene, we calculated RPKM [26]. Among our data, ,700
genes with average RKPM .1 were ‘‘called’’ absent on micro-
arrays. If we had relied on microarray to identify ‘‘expressed’’
genes, these genes and the genes that were not represented on the
microarrays would have been excluded in our analyses.
To check the accuracy of our RNA-Seq results, we compared
the expression levels with those from our microarray and
genotypes from our sequencing data with those obtained by
HapMap Consortium. For each gene, we calculated correlation
coefficient of the expression levels between the two platforms
across the 41 samples. The average correlation coefficient was 0.76
(median=0.76; range=0.73 to 0.80). For each sample, we also
identified the homozygous genotypes (AA, CC, GG, TT; ,25,000
genotypes per sample) using the HapMap database and compared
them to genotypes in our sequencing results. The comparisons
showed a high degree of agreement. Across the 41 samples, the
average concordance rate is 98.6% (median=98.7%).
Network Analysis
The gene regulatory network was constructed based on pairwise
regulatory relationship identified through linkage (t.4) and
QTDT analyses (p,0.05). Connections (edges) were placed
between genes that were implicated in a regulator-target inter-
action. Properties of the resulting gene regulatory network were
analyzed in MATLAB (MathWorks) by representing regulatory
relationships as an asymmetric adjacency matrix. The number of
incoming and outgoing connections per gene was determined by
summing the columns and rows of the adjacency matrix. A
MATLAB function for determining the scale-free topology criteria
was implemented as previously described [48]. Code will be
provided upon request. Figures of the resulting networks were
drawn using Cytoscape 2.6.0 [71]. To identify genes that have
been implicated as human disease susceptibility genes, we queried
the Catalogue of Genome-Wide Association Studies (http://www.
genome.gov/26525384) [72].
Functional Pathway Analysis
To determine whether a regulator and its target belong to the
same functional groups, we examined Gene Ontology Biological
Process terms [46] for the regulator and the target genes. We
counted the number of regulator-target pairs with identical Gene
Ontology Biological Process annotations; these were the ‘‘observed
counts.’’ We then examined 1,000 randomly chosen gene pairs
(from expressed genes in our B-cells) and counted the number of
gene pairs that shared Gene Ontology Biological Process annota-
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‘‘expected counts.’’ We compared the observed to the expected
counts by a chi-square test.
Knockdown of Candidate Regulators
Immortalized B cells of four to six individuals and primary
fibroblasts (foreskin) from two healthy newborns were used. The
cells were transfected with Accell siRNAs (Thermo Scientific)
against candidate regulators or non-target control according to the
manufacturer’s instructions. For each regulator, we used a pool of
siRNAs that target the regulators in order to minimize off-target
effects [36]. To compare the knockdown by pools of siRNA and
single siRNAs against a gene, we silenced GPHN using a pool of
siRNA and 2 siRNAs against different parts of the gene; similar
results were obtained in the three experiments (see Table S3B).
For each transfection, immortalized B cells were seeded at a
concentration of 4.5610
5 cells per 750 ul on the day of trans-
fection. 7.5 ul of 100 uM Accell siRNA was mixed with the seeded
culture. Each transfection mix was then plated in a 96-well tissue
culture plate in 150 ul aliquots. Similarly, 4.5610
5 cells per 750 ul
of primary fibroblasts were plated in 12-well plates in growth
media the day before the transfection. On the day of transfection,
the growth media were removed and replaced with 7.5 ul 100 um
Accell siRNA (against genes of interest or scrambled sequence as
control) and 750 ul of Accell media.
The transfected cells with siRNAs were incubated at 37uC for
96 h. We then replaced the Accell media with regular growth
media (RPMI 1640 with 15% fetal bovine serum, 2 mM L-
glutamine, and 100 U/mL penicillin-streptomycin) and let the
cells recover for 24 h. RNA was extracted using Qiagen RNeasy
kits. Effects of siRNA on gene expression were analyzed by
quantitative PCR (Applied Biosystems). Expression of ACTB was
used for normalization and changes in expression were calculated
relative to cells transfected with non-target control siRNA.
Sequences of PCR primers and siRNAs are presented in Tables
S4 and S5.
Insulin Treatment
For the western analysis: primary fibroblasts were cultured in
MEM medium supplemented with 10% fetal bovine serum, 2 mM
L-glutamine, and 100 U/mL penicillin-streptomycin. Cells were
serum starved for 18 h before treatment with 100 nM insulin for
5 min. Cells were lysed in 16 Lysis buffer (20 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1%
Triton 6100) (Cell Signaling) supplemented with 16 Complete
protease inhibitors (Roche) and 16phosphatase inhibitors I and II
(Sigma). Cell lysates containing 150 mg of total protein were
incubated with 5 mgo fa-INSR antibody (#3025, Cell Signaling)
or a-IGF1R antibody (#3018, Cell Signaling) at 4uC overnight.
Immuno-complex was pulled down using Protein A Sepharose
(GE Healthcare). Input and immunoprecipitation samples were
analyzed by Western Blot using a-phosphotyrosine (1:1000) (4G10
Platinum, Millipore) or the above a-INSR (1:1000) and a-IGF1R
(1:1000) antibodies.
For the gene expression analysis, primary fibroblasts (from
foreskin) of four individuals were cultured as above. Cells were
serum starved overnight (18 h) before being treated with 100 nM
insulin (Sigma) for 0, 1, 2, 6, or 12 h. RNA was extracted and gene
expression was analyzed by quantitative PCR (Applied Biosys-
tems). Sequences of PCR primers are presented in Table S6.
Comparison to Hi-C Data
Hi-C data from Dekker and colleagues [39] were obtained from
NCBI GEO (GSE189199); we used the data in their alignment
summaries. We compared their list of interacting pairs to our
regulator–target gene pairs. A match is called when one of their
interacting pair coordinates was found within a regulator or 5 kb
up- or downstream and the matching member of that pair is found
within or 5 kb up- or downstream of the corresponding target
gene. Seventy-five such pairs were found.
The experimental steps in this study are summarized by a
flowchart (Figure S3).
Accession Numbers. The data have been deposited to
NCBI GEO under the accession numbers GSE16778 and
GSE16921 for the microarray and RNA-Seq data, respectively.
Supporting Information
Figure S1 Differential allelic expression by RNA-Seq.
Allelic expression ratio of 273 exonic SNPs in 43 genes. Data for
each heterozygous individual is represented as a color dot. SNPs
are ordered left to right by mean expression ratio, a/(a+b).
Found at: doi:10.1371/journal.pbio.1000480.s001 (5.83 MB
TIF)
Figure S2 Examples of subnetworks that include genes
that were implicated as disease susceptibility in ge-
nome-wide association (GWA) studies (http://www.
genome.gov/gwastudies/).
Found at: doi:10.1371/journal.pbio.1000480.s002 (1.65 MB
PNG)
Figure S3 Flowchart showing experimental steps.
Found at: doi:10.1371/journal.pbio.1000480.s003 (0.08 MB
PDF)
Table S1 Linkage, QTDT, and association results for
cis-regulated genes.
Found at: doi:10.1371/journal.pbio.1000480.s004 (0.07 MB PDF)
Table S2 Regulators for 200 trans-regulated expression
phenotypes.
Found at: doi:10.1371/journal.pbio.1000480.s005 (0.06 MB PDF)
Table S3 Additional results of knockdown of trans-
regulators. (A) Knockdown of trans-regulators in fibroblasts. (B)
GPHN knockdown using a pool of 4 siRNAs compared to
individual siRNAs.
Found at: doi:10.1371/journal.pbio.1000480.s006 (0.10 MB PDF)
Table S4 Primer sequences for qRT-PCR (gene knock-
down experiment).
Found at: doi:10.1371/journal.pbio.1000480.s007 (0.04 MB PDF)
Table S5 siRNA sequences (gene knockdown experi-
ment).
Found at: doi:10.1371/journal.pbio.1000480.s008 (0.05 MB PDF)
Table S6 Primer sequences for qRT-PCR (insulin
treatment).
Found at: doi:10.1371/journal.pbio.1000480.s009 (0.03 MB
DOC)
Table S7 Regulator–target gene pairs that are found to
interact physically by Hi-C.
Found at: doi:10.1371/journal.pbio.1000480.s010 (0.05 MB PDF)
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